Literature DB >> 6288757

Concurrent production of adrenocorticotropin and prolactin from two distinct cell lines in a single pituitary adenoma: a detailed immunohistochemical analysis.

S H Sherry, A T Guay, A K Lee, E T Hedley Whyte, M Federman, S R Freidberg, P D Woolf.   

Abstract

A pituitary tumor from a patient with severe Cushing's disease and marked hyperprolactinemia was extensively studied by immunohistochemical techniques. Tissues from two separate areas of the adenoma were found to contain similar cell proportions of PRL as well as ACTH and related peptides (beta-lipotropin, beta-endorphin, and alpha MSH). The tumor was composed of approximately 70% immunoreactive PRL cells and 5% ACTH-containing cells. Double immunostaining revealed that PRL or ACTH and related peptides were found in two distinct populations of tumor cells. These results document for the first time inappropriate synthesis and secretion of an unusual combination of pituitary hormones from a mixed pituitary adenoma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288757     DOI: 10.1210/jcem-55-5-947

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.

Authors:  M Barausse; R Attanasio; D Dallabonzana; G Oppizzi; S Veronese; G Lasio; L G Valentini; R Cozzi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

2.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

3.  Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.

Authors:  G Verde; P Loli; M E Berselli; M Tagliaferri; D Dallabonzana; G Oppizzi; A Liuzzi; P G Chiodini; G Luccarelli; S Lodrini
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

4.  Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases.

Authors:  T Sano; K Kovacs; S L Asa; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Authors:  G T'Sjoen; I Defeyter; J Van De Saffele; R Rubens; M Vandeweghe
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 6.  Double pituitary lesions in three patients with Cushing's disease.

Authors:  B P Meij; M B Lopes; M L Vance; M O Thorner; E R Laws
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

Review 7.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

8.  Selective bilateral blood sampling from the inferior petrosal sinus in Cushing's disease: effects of corticotropin-releasing factor and thyrotropin-releasing hormone on pituitary secretion.

Authors:  T R Strack; H H Schild; J Bohl; J Beyer; J Schrezemeir; G Kahaly
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

9.  Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

Authors:  S Akita; J Webster; S G Ren; H Takino; J Said; O Zand; S Melmed
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia.

Authors:  Cheng Huan; Chao Lu; Guang-Ming Xu; Xin Qu; Yuan-Ming Qu
Journal:  Int J Endocrinol       Date:  2014-11-23       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.